Additionally, glioma cells (GMs) enhance glucose consumption and lactate production via increasing the levels of monocarboxylate transporter 1 (MCT1) and the cluster of differentiation 147 (CD147) and their localization at the plasma membrane to remove intracellular lactate out of cells to maintain continuous glycolysis. The gene discussed is SLC16A1; the disease is glioma.